The role of placebo response in the efficacy outcome assessment in viloxazine extended‐release pivotal trials in paediatric subjects with attention‐deficit/hyperactivity disorder-论文-万方医学网

首页> > The role of placebo response in the efficacy outcome assessment in viloxazine extended‐release pivotal trials in paediatric subjects with attention‐deficit/hyperactivity disorder

The role of placebo response in the efficacy outcome assessment in viloxazine extended‐release pivotal trials in paediatric subjects with attention‐deficit/hyperactivity disorder

导出原文传递

翻译打印收藏纠错

第一作者： Azmi Nasser

作者： Azmi Nasser ^[1] ; Roberto Gomeni ^[2] ; Zhao Wang ^[3] ; Joseph T. Hull ^[4] ; Gregory D. Busse ; Zare Melyan ; Maurizio Fava ; Welton O'Neal ; Jonathan Rubin

作者单位： Supernus Pharmaceuticals, Inc. ^[1] Pharmacometrica, Lieu‐dit Longcol, La Fouillade ^[2] Formerly with Supernus Pharmaceuticals, Inc. ^[3] Department of Psychiatry,Massachusetts General Hospital ^[4]

关键词 ADHD ADHD‐RS‐5 attention‐deficit/hyperactivity disorder band‐pass analysis placebo response treatment effect viloxazine extended‐release

发布时间 2022-12-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

The role of placebo response in the efficacy outcome assessment in viloxazine extended‐release pivotal trials in paediatric subjects with attention‐deficit/hyperactivity disorder

相似文献

同项目论文

相关期刊

检索历史 清除

The role of placebo response in the efficacy outcome assessment in viloxazine extended‐release pivotal trials in paediatric subjects with attention‐deficit/hyperactivity disorder

相似文献

同项目论文

相关期刊

检索历史清除